MANE (Veradermics) Net Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MANE Veradermics Inc MANE
12 GF Score
Price $109.49
! 1 Warning Sign
View Full Analysis

What is Veradermics Net Margin %?

Veradermics MANE +3.25% 12 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates MANE with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 942 Biotechnology companies, Veradermics ranks worse than 106157.01% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Veradermics's Net Income for the three months ended in Mar. 2026 was $-27.23 Mil. Veradermics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Veradermics's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Veradermics's Net Margin % or its related term are showing as below:


MANE's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.295
* Ranked among companies with meaningful Net Margin % only.

Veradermics  (NYSE:MANE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Veradermics Net Margin % Related Terms

Veradermics Net Margin % Historical Data

* Premium members only.

The historical data trend for Veradermics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veradermics Net Margin % Chart

Veradermics Annual Data
Trend Dec23 Dec24 Dec25
Net Margin %
0.00 0.00 0.00

Veradermics Quarterly Data
Dec23 Dec24 Mar25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

MANE vs CAI, DNTH, CRSP: Net Margin % Comparison

For the Biotechnology subindustry, Veradermics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veradermics Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veradermics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Veradermics's Net Margin % falls into.


MANE
12GF Score
Veradermics Inc MANE
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veradermics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Veradermics's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-69.995/0
= %

Veradermics's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-27.232/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Veradermics (MANE) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Veradermics and its competitors. According to the industry distribution chart, Veradermics ranks #999999 out of 942 companies in the Biotechnology industry.
Is Veradermics' Net Margin % too high?
Veradermics' current Net Margin % is 0.00%. Based on the distribution chart, Veradermics ranks #999999 out of 942 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Veradermics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Veradermics' Net Margin % compare to CAI and DNTH?
According to the Biotechnology industry distribution chart, Veradermics ranks #999999 out of 942 companies for Net Margin %. This places Veradermics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Veradermics and its competitors. Veradermics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradermics stock overvalued right now?
Veradermics (MANE) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Veradermics' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Veradermics (MANE), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veradermics Business Description

Address 470 James Street, New Haven, CT, USA, 06513
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
12GF Score

Get the complete analysis for MANE

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$109.49
Price